Article Details
Retrieved on: 2025-05-09 08:32:48
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses INmune Bio Inc.'s financial activities and products aimed at healing via biotechnology involving TNF inhibitors and NK cells. The financials and tags relate as they describe the company's assets, liabilities, and equity linked to the development and trials of healing therapies.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here